Millipore Buys Guava for $22.6M; Aims to Bring Integrated Cell-Analysis Tool to Benchtop | GenomeWeb

Millipore this week announced it plans to acquire Hayward, Calif.-based Guava Technologies, a producer of benchtop cellular analysis systems, for $22.6 million.

Alan Weiss, director of strategy and business development for Millipore’s bioscience division, said that the purchase, expected to close in the next several weeks, will provide its customers with a powerful cell biology/protein expression-analysis tool for the benchtop.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.

In Science this week: genetic target for urothelial bladder cancer treatment, and more.

At the Conversation, the University of Oxford's Michael Macklay writes that learning genetic risk of disease is a personal decision.

Two dozen scientific organizations have endorsed the March for Science, according to ScienceInsider.

Researchers in Japan describe a chimpanzee with a chromosomal abnormality similar to human Down syndrome, Mashable reports.